The Comparison of Anticancer Efficiency of Methylene Blue- and Aluminum Phthalocyanine-Mediated Sonophotodynamic Therapy on Prostate Cancer Cells In Vitro. (2026)

Peer-Reviewed Study · Aksel M; Bozkurt Girit O; Ozmen A; Bilgin MD · March 20, 2026

Aksel M et al., 2026-03-20: Turkish in vitro comparison finding methylene blue outperformed aluminium phthalocyanine in photodynamic, sonodynamic and combined sonophotodynamic treatment of androgen-sensitive and androgen-insensitive prostate cancer cells, with apoptotic markers raised.

Results showed significant proliferation inhibition, with SPDT exhibiting the highest efficacy. MB demonstrated superior efficiency compared to AlPc.

Aksel M et al., 2026-03-20: Turkish in vitro comparison finding methylene blue outperformed aluminium phthalocyanine in photodynamic, sonodynamic and combined sonophotodynamic treatment of androgen-sensitive and androgen-insensitive prostate cancer cells, with apoptotic markers raised. C3 Aksel 2026 (prostate). Study type: in vitro comparative study using 'androgen-sensitive and androgen-insensitive prostate cancer cell lines' – the abstract does not name the lines (no LNCaP/PC-3 names in the abstract text captured), and the full text is paywalled, so line identity is unconfirmed. Country: Turkey. Dose: 'different concentrations of MB and AlPc' – values not in the abstract. Light required: yes (light and/or ultrasound arms). Funder/conflicts: not in the record. Comparator: AlPc, and PDT vs SDT vs SPDT arms. Note MTT measures metabolic activity, not clonogenic survival, as the authors themselves state. Also filed as MTN-01 (claims C1, C3). Study type: lab.